The capacity to measure the impact of an intervention on long-term functional outcomes might be improved if research methodology reflected our clinical approach, which is to individualise goals of care to what is achievable for each patient. The objective of this multicentre inception cohort study was to evaluate the feasibility of rapidly and accurately categorising patients, who were eligible for simulated enrolment into a clinical trial, into unique categories based on premorbid function. Once a patient met eligibility criteria a rapid 'baseline assessment' was conducted to categorise patients into one of eight specified groups. A subsequent 'gold standard' assessment was made by an independent blinded assessor once patients had recovered sufficiently to allow such an assessment to occur. Accuracy was predefined as agreement in >80% of assessments. One hundred and twenty-two patients received a baseline assessment and 104 (85%) were categorised to a unique category. One hundred and six patients survived to have a gold standard assessment performed, with 100 (94%) assigned to a unique category. Ninety-two patients had both a baseline and gold standard assessment, and these agreed in 65 (71%) patients. It was not feasible to rapidly and accurately categorise patients according to premorbid function.
Background
Physical function and cognitive capacity are outcomes of considerable importance to patients who survive critical illness 1 . For this reason, large randomised controlled trials (RCTs) of interventions during critical illness routinely report post-discharge functional and cognitive outcomes [2] [3] [4] [5] . There are considerable resources dedicated to the measurement of these outcomes with a large number of instruments used, many of which are relatively labour-intensive and costly to administer 1, [6] [7] [8] . Despite these considerable resources, many RCTs have reported that the intervention being studied had minimal to no effect on long-term functional outcomes 2, 3, [9] [10] [11] [12] [13] [14] .
While a lack of measured effect may be because the interventions tested are actually ineffective, an alternative hypothesis is that the conventional clinical trial practice of measuring the same endpoint for all study participants is too blunt to detect meaningful differences 15 . The latter explanation is particularly concerning, as the result of an otherwise well-conducted RCT may cause us to discard a treatment that has clinically meaningful benefits, or, perhaps worse, continue to use a treatment that causes harm. For this reason, there is persuasive rationale that outcomes are interpretable relative to the specific circumstances of patients or their presenting problem.
Parallels can be drawn from recent neurocritical care literature. Outcomes are traditionally assessed using an ordinal outcome measure, the six-month Glasgow Outcome Scale or Extended Glasgow Outcome Scale, which are frequently then dichotomised into favourable or unfavourable outcomes 16, 17 . However, collapsing continuous or ordinal values into a binary variable discards valuable information 18 . Attempts have been made to provide more nuanced understanding of the effect of an intervention within an RCT by using information prior to, or at, randomisation to predict potential disability, and using analytical techniques, such as proportional odds models or sliding dichotomies, to evaluate the binary variable of an unfavourable or favourable outcome 17, 19, 20 . Theoretically this concept allows the effect of an intervention to be measured relevant to the severity of the presenting problem 21 , and is increasingly used to report outcomes in neurocritical care RCTs 22, 23 .
Another example of an approach that attempts to quantify outcomes relevant to an individual's situation is the use of health-related quality of life scores 24 . However, limitations of currently available health-related quality of life scores include that the majority of the instruments used are generic rather than specific to critically ill patients 25, 26 -albeit that some tools, such as the Short Form 36 (SF-36), have reasonable validity in the critically ill 27, 28 . Additional limitations of health-related quality of life scores include issues related to ceiling and floor effects 29 . Finally, if the objective is to take into account the individual patient's circumstances prior to ICU admission, there is a need to perform a retrospective measurement using the patient's family or friend with the resultant inaccuracies 30, 31 . Moreover, it appears that many of these instruments may not be sufficiently responsive to detect small but clinically meaningful changes across a heterogeneous population within an RCT 15, 32 .
The ability to detect the impact of an intervention on longterm outcomes within RCTs might therefore be improved if research methodology reflected a common clinical approach, which is to individualise goals of care to what is achievable for each patient 15 . Ideally however, the features that will be used to predict outcomes for an individual patient within an RCT should be identified prior to treatment allocation and patients assigned to mutually exclusive and exhaustive categories of premorbid function. Such an approach may then allow measurement of individualised endpoints relevant to different subgroups.
Because the concept of categorising patients within a clinical trial is relatively novel, we conducted the Rapid and Accurate Categorisation of critically ill patients (RACE) feasibility study to assess whether research coordinators could rapidly and accurately categorise critically ill patients into one of eight pre-specified unique categories of premorbid function.
Methods
We performed an inception cohort study in four hospitals with experienced research coordinators: Royal Adelaide Hospital, The Queen Elizabeth Hospital, Alfred Hospital (Australia) and Wellington Hospital (New Zealand). The research ethics committees of the relevant jurisdictions approved the study protocol using initial delayed opt-out consent from the patient's surrogate decision-maker. At the first available opportunity, and before the gold standard assessment, the next of kin or, when he/she was deemed competent, the patient, was approached and given the opportunity to opt out. Our study was performed according to National Health and Medical Research Council of Australia guidelines for the conduct of research on unconscious patients and registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615000942550).
Patients
All patients admitted to the intensive care unit (ICU) of the participating centres were screened. Patients were eligible if in the preceding 96 hours they met the eligibility criteria used for a recently completed study conducted in our region 33 ; that is, they were 18 years or older, intubated and receiving mechanical ventilation, about to commence enteral nutrition (EN) or EN had been commenced within the previous 12 hours, and they were expected to be receiving EN in ICU until at least the day after tomorrow. Patients were excluded if they had received any EN or parenteral nutrition (PN) for more than 12 hours in this ICU admission, death was deemed to be imminent or inevitable during this admission, underlying disease made survival to 90 days unlikely or they had ≥15% acute burn injury 33 .
Outcome measures
After round table discussions we selected eight categories of premorbid function that we considered to be mutually exclusive and exhaustive. These categories and the rationale underlying their selection have been published previously 15 . In brief, these were: 1) aged <65 years and in paid employment (or unemployed but looking for paid employment); 2) aged <65 years and studying; 3) aged <65 years and chronically disabled (physical or mental); 4) aged <65 years and 'socially disadvantaged', such that environmental or societal factors impair capacity to work; 5) aged <65 years and involved in non-paid work; 6) aged ≥65 years and living independently without essential supports; 7) aged ≥65 years and living independently with essential supports; and 8) aged ≥65 years and living in supported accommodation.
Study protocol
If a patient was eligible for study participation research coordinators would assess and determine which category the patient should be assigned to. This was defined as the baseline assessment. To imitate the time constraints that occur within a large RCT, research coordinators were encouraged to conduct the initial categorisation within 96 hours of ICU admission. Using a case report form (summarised in Table 1 ) and immediately available information from the medical record or discussion with the bedside nurse, social worker, treating clinician or, when immediately available, the family, research coordinators allocated each participant to a baseline assessment category.
Research coordinators also recorded the time taken to categorise the patient and rated from 1 (least certain) to 10 (most certain) how certain they were the category chosen would be the same if they had the opportunity to discuss which category to choose with the patient.
The 'gold standard' assessment was made by an independent blinded assessor once the patient was extubated from mechanical ventilation for 24 hours or more and able to answer questions, or upon ICU discharge (whichever occurred first). This assessor could be another research coordinator, study investigator, medical officer, or social worker who was blinded to the initial research coordinator baseline categorisation. The blinded assessor approached the patient and/or next of kin and provided them with verbal and written information. This assessor used a semi-structured interview guide and their judgement to ascertain the correct category (Supplemental file 1). They were instructed that the objective of their assessment was 'to get to the truth'; if the blinded assessor was uncertain about the information obtained at the initial gold standard interview they then kept searching for the best source of information. We only used a proxy when a patient was unable to provide this information (e.g. because of an acquired brain injury).
Statistical analysis
Data are shown as mean values (95% confidence intervals [CI]) unless otherwise stated. The fraction of patients with an exact match between the baseline categorisation and gold standard assessment was calculated with acceptable accuracy defined as agreement in >80% of assessments. Our primary outcome was accuracy and using 1-β 0.8 and one-sided α 
Results

Study period
We anticipated that the period September to December 2015 would allow us to enrol and complete baseline and gold standard assessments in 120 participants. Because of slower than anticipated enrolment the study period was extended two months with recruitment closed at the end of February 2016.
Study participants
During the study period 155 patients met all inclusion criteria with 32 excluded leaving 123 patients who had an initial assessment performed. One patient later declined to participate, leaving 122 included in the analysis (Figure 1 ). Participants were recruited from all four hospitals. Eighty-six (71%) participants were men and the mean age was 54.9 (51.8, 58.0) years.
Baseline assessments
Twelve research coordinators performed baseline assessments. The baseline assessments were completed 2.4 (1.6, 3.1) days after ICU admission and the time taken to perform the baseline assessment was 5.9 (4.9, 7.0) minutes. The sources of information used for these assessments are detailed in Table 2A and 2B. One hundred and four (85%) of the 122 participants were able to be categorised to a unique category. Eleven (9%) participants were unable to be categorised with seven (6%) participants categorised to two categories. Numbers of participants assigned to each category (baseline and gold standard) are provided in Table  2 . Research coordinators' self-reported confidence in the accuracy of their categorisation was 8.2 (7.9, 8.6) .
Gold standard assessment
Gold standard assessments were performed by 10 research coordinators (95% of patients) and two intensivists (5% of patients). For those who survived (n=106 [87% of all patients]) to a gold standard assessment, 100/106 (94%) participants were able to be categorised to a unique and complete category. Of the 18 who did not receive a gold standard interview, 16 patients had died and two were discharged before a gold standard interview could take place (Figure 1 ). During gold standard assessment the categories that most patients were assigned to were: in paid employment (n=40); chronic disability (n=19); and aged ≥65 years and living independently without supports (n=18). There was an uneven spread of patients assigned to each category with several categories having relatively few patients assigned: working not paid (n=4), living in supported accommodation (n=4), socially disadvantaged (n=1) or studying (n=0).
Accuracy
Ninety-two patients had a unique category assigned for both baseline and gold standard assessments (Figure 1 ). Categorisation during baseline assessment agreed with categorisation during gold standard assessment for 65/92 (71% [60%, 80%]) participants ( Table 2 ). The observed accuracy was greatest in patients aged ≥65 years and living independently without supports and in patients aged <65 years in paid employment ( Table 2 ).
Discussion
Our primary finding is that we were unable to rapidly and accurately categorise critically ill patients into one of eight pre-specified unique categories of premorbid function. Moreover, there were several categories that relatively few patients were assigned to and, in general, the accuracy appeared poorest in these categories.
The categories selected were based on several factors. These included categories which we considered to constitute a desirable outcome, e.g. for a person working prior to their ICU admission we proposed that returning to work represented a desirable and measurable outcome 34 . In addition, we sought to include categories for which outcome measures already exist and have been validated, e.g. surveys conducted in gerontology offer a useful snapshot of lifestyle activities for older persons who live independently in the community without supports 35 . However, we also wished to avoid an excessive number of categories because categories with small numbers of participants would potentially limit our ability to detect differences in a subsequent RCT 15 . One potential explanation for our failure to accurately categorise patients rapidly is that eight categories is too many. Excludes patients unable to be assigned at baseline or gold standard assessment.
Baseline Assessment
Comparison to other data
There is considerable interest in research methodology that provides greater certainty that any given RCT has provided the true result to inform decision-making for individual patients rather than populations. Our study represents an attempt to individualise outcomes within a simulated RCT; however, there has been considerable work by several other groups to try to improve power within RCTs without increasing sample sizes. These approaches have varied between altering enrolment criteria, such as considering relevant biomarker concentrations or the initial response to therapy 36, 37 , stratifying patients based on baseline risk of death 21, 38 , or analysis techniques such as proportional odds models or sliding dichotomies 17, 39 .
Strengths and limitations
The limitations of our study included that minimal funding was available, which prevented usual practice of 'start-up' meetings, group training for the specific research coordinators involved, and on-site data monitoring. Wellfunded training and monitoring processes may have prevented patients being categorised to two separate categories. Due to the relatively small number of assessments at each site and the number of research coordinators we were also unable to determine if accuracy improved with training. In addition, our study was conducted using the enrolment criteria for a recently completed study 33 , but not within an RCT per se. Accordingly, the results may have differed from those obtained if categorisation were occurring in a well-funded RCT.
A strength of our study was that it was conducted across four locations, with each site having research coordinators dedicated to research activities, and we submit that it provides a reasonable initial assessment of the categorisation scheme's feasibility in our region.
Future directions
If our proposal to try and categorise patients within a clinical trial is considered a reasonable approach to pursue, our feasibility study indicates that modifications to the methodology are required to operationalise such an approach. Specifically, it appears that more time should be allocated to complete the initial categorisation and strict priority rules be incorporated to prevent assigning to more than one category. Furthermore, we evaluated the use of eight categories and several categories had only small numbers, indicating that these could be integrated.
Conclusions
Using the enrolment criteria for a multicentre RCT we were unable to rapidly and accurately categorise patients into one of eight unique categories of premorbid function promptly after ICU admission.
